Talphera Inc (FRA:R5XA)
€ 0.46 -0.138 (-23.08%) Market Cap: 8.66 Mil Enterprise Value: -1.23 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 39/100

AcelRx Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 07:00PM GMT
Release Date Price: €24.04 (+1.78%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

My name is Evan Seigerman. I'm the Senior Biopharma Analyst here at Crédit Suisse. Welcome to day 2 of the Crédit Suisse Virtual Global Healthcare Conference. We're looking forward to hopefully having everyone in person next year, but Zoom and the virtual setting suffices for now.

With me today I have AcelRx, and from AcelRx, I've Vince Angotti, CEO; and Raffi, I always pronounce it wrong, Asadorian, the CFO. Vince, take it away.

Vincent J. Angotti
AcelRx Pharmaceuticals, Inc. - CEO & Director

Thank you, Evan. I'll get off the video here and be sure I can see the screen, and hopefully, everyone can see that. First, let me thank you, Evan and Crédit Suisse for including us in your conference this year. We're flattered to be here. I'd also like to thank those of you joining us online for your interest in AcelRx, it's much appreciated.

Before we begin, I'll remind you that we'll be making forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot